Medical Economics September 17, 2024
The pharmaceutical industry has increasingly taken aim at the program for growing costs, but is that accurate? American Hospital Association analysts offer this perspective.
The 340B Drug Pricing Program was created by Congress in 1992 to help hospitals and other safety-net providers manage high and increasing drug prices — an issue that persists today. The 340B program is an excellent example of a public-private partnership, where pharmaceutical companies are incentivized to offer discounts on certain outpatient drugs to hospitals and other providers that care for high numbers of underserved patients in exchange for coverage of these drugs by Medicaid and Medicare, all without reliance on taxpayer dollars.
In effect, 340B benefits everyone — pharmaceutical companies get their drugs covered by...
Today's Sponsors
Today's Sponsor